Literature DB >> 29770104

Using bugs as drugs: Microbial ecosystem therapeutics.

E Allen-Vercoe1, E O Petrof2.   

Abstract

The human gut harbours a dense and highly diverse microbial ecosystem-the microbiota-that plays an important role in the maintenance of health. Modern lifestyle practices, including widespread antibiotic use, have degraded microbiota diversity, compromising the integrity of this vital ecosystem and creating susceptibility to diseases such as Clostridium difficile infection. Treatment of patients to restore the diversity of the gut microbiota offers a logical solution to disease. Although fecal microbial therapy (FMT) has started to gain traction as an effective method to effect this restoration, it is not without risks and there are significant barriers to its implementation in the clinic. Some of the risks and challenges with FMT are addressed by microbial ecosystem therapeutics (MET), an alternative approach to FMT that uses selected, defined microbial ecosystems to redress microbiota balance and functionality. The time has come for the use of bugs as drugs.

Entities:  

Year:  2015        PMID: 29770104      PMCID: PMC5868539          DOI: 10.14745/ccdr.v41is5a01

Source DB:  PubMed          Journal:  Can Commun Dis Rep        ISSN: 1188-4169


  28 in total

1.  Transfer of intestinal microbiota from lean donors increases insulin sensitivity in individuals with metabolic syndrome.

Authors:  Anne Vrieze; Els Van Nood; Frits Holleman; Jarkko Salojärvi; Ruud S Kootte; Joep F W M Bartelsman; Geesje M Dallinga-Thie; Mariette T Ackermans; Mireille J Serlie; Raish Oozeer; Muriel Derrien; Anne Druesne; Johan E T Van Hylckama Vlieg; Vincent W Bloks; Albert K Groen; Hans G H J Heilig; Erwin G Zoetendal; Erik S Stroes; Willem M de Vos; Joost B L Hoekstra; Max Nieuwdorp
Journal:  Gastroenterology       Date:  2012-06-20       Impact factor: 22.682

Review 2.  The gut flora as a forgotten organ.

Authors:  Ann M O'Hara; Fergus Shanahan
Journal:  EMBO Rep       Date:  2006-07       Impact factor: 8.807

Review 3.  A Canadian Working Group report on fecal microbial therapy: microbial ecosystems therapeutics.

Authors:  Emma Allen-Vercoe; Gregor Reid; Norman Viner; Gregory B Gloor; Susy Hota; Peter Kim; Christine Lee; Kieran O'Doherty; Stephen J Vanner; J Scott Weese; Elaine O Petrof
Journal:  Can J Gastroenterol       Date:  2012-07       Impact factor: 3.522

Review 4.  Antibiotics and the gut microbiota.

Authors:  Sheetal R Modi; James J Collins; David A Relman
Journal:  J Clin Invest       Date:  2014-10-01       Impact factor: 14.808

5.  Continuous Proton Pump Inhibitor Therapy and the Associated Risk of Recurrent Clostridium difficile Infection.

Authors:  Emily G McDonald; Jonathon Milligan; Charles Frenette; Todd C Lee
Journal:  JAMA Intern Med       Date:  2015-05       Impact factor: 21.873

Review 6.  Clostridium difficile spores: a major threat to the hospital environment.

Authors:  Jonathan Barra-Carrasco; Daniel Paredes-Sabja
Journal:  Future Microbiol       Date:  2014       Impact factor: 3.165

7.  Structure, function and diversity of the healthy human microbiome.

Authors: 
Journal:  Nature       Date:  2012-06-13       Impact factor: 49.962

8.  Changes in human fecal microbiota due to chemotherapy analyzed by TaqMan-PCR, 454 sequencing and PCR-DGGE fingerprinting.

Authors:  Jutta Zwielehner; Cornelia Lassl; Berit Hippe; Angelika Pointner; Olivier J Switzeny; Marlene Remely; Elvira Kitzweger; Reinhard Ruckser; Alexander G Haslberger
Journal:  PLoS One       Date:  2011-12-14       Impact factor: 3.240

Review 9.  What are the consequences of the disappearing human microbiota?

Authors:  Martin J Blaser; Stanley Falkow
Journal:  Nat Rev Microbiol       Date:  2009-11-09       Impact factor: 78.297

10.  Stool substitute transplant therapy for the eradication of Clostridium difficile infection: 'RePOOPulating' the gut.

Authors:  Elaine O Petrof; Gregory B Gloor; Stephen J Vanner; Scott J Weese; David Carter; Michelle C Daigneault; Eric M Brown; Kathleen Schroeter; Emma Allen-Vercoe
Journal:  Microbiome       Date:  2013-01-09       Impact factor: 14.650

View more
  1 in total

1.  Microbiome as an Immunological Modifier.

Authors:  Manoj Kumar; Parul Singh; Selvasankar Murugesan; Marie Vetizou; John McCulloch; Jonathan H Badger; Giorgio Trinchieri; Souhaila Al Khodor
Journal:  Methods Mol Biol       Date:  2020
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.